Entry into the Chinese DES market through the acquisition of Essen Technology
A standalone M&A theme focused on entering China’s DES market by acquiring 易生科技 (Essen Technology) and obtaining a platform for the development, production and sale of drug-eluting coronary stents (DES).
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.